To ensure a comfortable and effective injection, its essential to rotate between these sites each time you administer the medication
A key differentiator of Mardrigals resmetirom is that in a pivotal Phase 3 trial, it achieved both primary endpoints of NASH resolution and reduction in fibrosis (MAESTRO-NASH), the two liver histological improvement endpoints the FDA has proposed as reasonably likely to predict clinical benefit
However, it is difficult to ascertain whether this was due to specific biology or the lack of statistical power after adjustment for multiplicity in STEP 2 due to a smaller sample size
Contact your doctor immediately if you experience any
"Weight Loss Medications." Published on PMC, Accessed on November 13, 2023 at American College of Cardiology (ACC)
Whether youre embarking on a weight-loss journey or seeking solutions for improved metabolic health, were here to guide you every step of the way